# IBERE PHARMACEUTICALS (IBERU)

> Institutional ownership reported to the SEC as of Q4 2022, from Form 13F filings. Source: https://holderbook.com/stocks/IBERU/

- Reporting holders: 10
- Reported value: $4.0M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Schechter Investment Advisors, LLC](https://holderbook.com/funds/1951586-schechter-investment-advisors-llc/) | $1.8M | 175,562 | 0.2% | 5 |
| [HRT FINANCIAL LP](https://holderbook.com/funds/1475597-hrt-financial-lp/) | $649.0K | 64,980 | 0.0% | 8 |
| [JANE STREET GROUP, LLC](https://holderbook.com/funds/1595888-jane-street-group-llc/) | $573.0K | 57,472 | 0.0% | 8 |
| [LANDSCAPE CAPITAL MANAGEMENT, L.L.C.](https://holderbook.com/funds/1536186-landscape-capital-management-l-l-c/) | $365.7K | 36,568 | 0.1% | 8 |
| [Terrapin Asset Management, LLC](https://holderbook.com/funds/1965645-terrapin-asset-management-llc/) | $186.0K | 18,510 | 0.2% | 1 |
| [Wealthspring Capital LLC](https://holderbook.com/funds/1844495-wealthspring-capital-llc/) | $179.9K | 18,040 | 0.3% | 8 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $158.5K | 15,899 | 0.0% | 8 |
| [Sage Mountain Advisors LLC](https://holderbook.com/funds/1832274-sage-mountain-advisors-llc/) | $131.6K | 13,200 | 0.0% | 8 |
| [GLAZER CAPITAL, LLC](https://holderbook.com/funds/1076809-glazer-capital-llc/) | $10.0K | 1,000 | 0.0% | 4 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $6.0K | 600 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q4 2022 | 10 | $4.0M |
| Q3 2022 | 13 | $6.1M |
| Q2 2022 | 18 | $29.5M |
| Q1 2022 | 18 | $17.7M |
| Q4 2021 | 22 | $40.5M |
| Q3 2021 | 27 | $50.8M |
| Q2 2021 | 34 | $61.7M |
| Q1 2021 | 60 | $121.3M |